Strong dividend payers can be a stabilizing force in a well-diversified portfolio. That's because corporations that can consistently pay and raise their payouts over a long period are often relativ...

AbbVie (ABBV -0.36%) is a drug company, spun off from Abbott Laboratories in 2013, that you might want to consider for your long-term portfolio. One of the biggest green flags for investing in the ...

You probably exercise significantly more caution before investing a lot of money than you do when investing a small amount. The more money at risk, the more risk-averse most of us become.

The biopharmaceutical company doesn't expect U.S. generic entry for the drug before 2037 now that it has settled litigation.

AbbVie's stock is on the rise, and for good reason! The company just reached a major agreement with generic drug manufacturers to delay the release of a generic version of its blockbuster drug, Rin...

AbbVie Inc. (NYSE:ABBV ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:00 AM EDT Company Participants Robert Michael - CEO & Chairman of the Board Jeffrey Stewart - E...

If investors select their dividend-paying stocks in a structured manner, they can create a portfolio that provides monthly paydays.

With patent-protected market exclusivity for their products, pharmaceutical companies reliably produce profits that they aren't shy about distributing to shareholders. In an industry already known ...

ABBV's expanding neuroscience portfolio, led by Botox, Vraylar and new launches like Vyalev, continues to fuel top-line growth.

The list of trillion-dollar stocks is small and doesn't feature a single medical company. That might change in the next decade, as several leading healthcare stocks have market caps that are inchin...

AbbVie, Amgen, Stryker and Dexcom are tapping into the booming silver economy with new therapies, tech and acquisitions aimed at aging populations.

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

Exercising patience might be the most difficult part of investing. However, I find it much easier to patiently own some stocks more than others.

You don't have to be rich to make money. Furthermore, you don't have to have a lot of money to begin making money almost immediately.

Short-term market fluctuations can be stressful, there's no doubt about that. The good news is, long-term investors are in a better position to weather these storms.